【法新社东京1981年11月22日电】据报道,东京一家制药公司和生化研究所共同研制成一种新的抗癌药,据说其作用比干扰素大50倍。他们把这种新的抗癌药物命名为“癌破坏因子”(Carcino-breaking factor,CBF)。它是在生产干扰素过程付产品中发现的一种物质,一种新的淋巴细胞运动素(lymphokine)的衍生物。他们已商定着手进行成批生产这种抗癌药物。 [AFP, Tokyo, November 22, 1981] It is reported that a pharmaceutical company in Tokyo and the Institute of Biochemistry developed a new anticancer drug that is said to be 50 times more effective than interferon. They named the new anticancer drug “Carcino-breaking factor” (CBF). It is a substance found in products that produce interferon, a novel derivative of lymphokine. They have agreed to proceed with mass production of the anti-cancer drug.